نتائج البحث

Fréquence de l’anémie chez les patients français atteints de tumeurs solides ou d’hémopathies malignes: résultats de l’«European Cancer Anaemia Survey (ECAS)».

• Authors : Schneider, M.¹

• Source: Oncologie (Tech Science Press). aug2005, Vol. 7 Issue 5, p397-402. 6p. 1 Diagram, 4 Charts, 4 Graphs.

تفاصيل العنوان

Opinion: Childhood solid tumours: a developmental disorder.

• Authors : Scotting, Paul J.¹ ; Walker, David A.²; Perilongo, Giorgio³

• Source: Nature Reviews Cancer. Jun2005, Vol. 5 Issue 6, p481-488. 8p.

تفاصيل العنوان

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours.

• Authors : Awada, A.¹ ; Hendlisz, A.¹; Gil, T.¹

• Source: British Journal of Cancer. 5/23/2005, Vol. 92 Issue 10, p1855-1861. 7p.

تفاصيل العنوان

Tumour markers in pediatric solid tumours.

• Authors : Singal, A. K.¹; Agarwala, S.¹

• Source: Journal of Indian Association of Pediatric Surgeons. Jul-Sep2005, Vol. 10 Issue 3, p183-190. 8p.

تفاصيل العنوان

INNOVATION: High-intensity focused ultrasound in the treatment of solid tumours.

• Authors : Kennedy, James E.¹

• Source: Nature Reviews Cancer. Apr2005, Vol. 5 Issue 4, p321-327. 7p.

تفاصيل العنوان

Solid tumours.

• Source: Bone Marrow Transplantation. Mar2005 Supplement, Vol. 35 Issue 1, pS254-S269. 16p.

تفاصيل العنوان

A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points.

• Authors : O'Donnell, A.^1,2 anne.o'; Padhani, A.³; Hayes, C.^1,2

• Source: British Journal of Cancer. 10/17/2005, Vol. 93 Issue 8, p876-883. 8p.

تفاصيل العنوان

Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse.

• Authors : Collier, Lara S.¹; Carlson, Corey M.¹; Ravimohan, Shruthi^1,2

• Source: Nature. 7/14/2005, Vol. 436 Issue 7048, p272-276. 5p.

تفاصيل العنوان

Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘Iressa’, ZD1839) in Phase I and II clinical trials.

• Authors : Tullo, A. B.¹ ; Esmaeli, B.²; Murray, P. I.³

• Source: Eye. Jul2005, Vol. 19 Issue 7, p729-738. 10p.

تفاصيل العنوان

An inhibitor of Bcl-2 family proteins induces regression of solid tumours.

• Authors : Oltersdorf, Tilman¹; Elmore, Steven W.²; Shoemaker, Alexander R.²

• Source: Nature. 6/2/2005, Vol. 435 Issue 7042, p677-681. 5p.

تفاصيل العنوان